Tenon Medical Inc. (TNON)
TNON trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1560293/000121390026035707/0001213900-26-035707-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | TNON on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | 2022 |
| SEC CIK | 0001560293 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $3.9M |
| Net income | -$12.6M |
| Operating income | -$12.8M |
| Net margin | -318.4% |
| Operating margin | -324.3% |
| Revenue growth | +20.4% |
| Cash | $3.8M |
| Total assets | $10.8M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 0.9× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | States substantial doubt about continuing as a going concern. "There is substantial doubt about the Company's ability to continue as a going concern for one year after the date that these financial statements are issued." | 10-Q 2026-08-13 |
| Cash and burn | $1.7M cash; operating cash flow -$2.9M a quarter. | Report 2026-06-30 |
| Shares outstanding | 667,047 (2026-08-13); 8,879,220 a year earlier; 22,612,856 three years earlier. 1y figure adjusted for splits (1-for-35 overall); 3y figure adjusted for splits (1-for-2800 overall). | Cover page 2026-08-13 |
| Reverse splits, 3 years | 2; latest 1-for-35 on 2026-08-10 | Source 2026-08-10 |
| Shelf and offerings, 12 months | 3 S-3/F-3 shelf filings; 1 424B5 takedowns | Latest 2026-10-16 |
| Exchange deficiency notices, 12 months | 2 (8-K item 3.01) | 8-K 2026-05-22 |
| Auditor | Haskell & White LLP, Irvine, California, United States | PCAOB Form AP 2026-05-02 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $500K, sold $606K on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
| Market cap check | The listing's market cap implies 2,688,735 shares at the 2026-11-13 price; the latest SEC cover count is 667,047 as of 2026-08-13. One of the two share counts is stale. | Nasdaq screener and SEC cover page |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q2 2026 2026-06-30 | $1.3M | -$4.0M | -$2.8M | $1.7M | $4.3M | $5.3M | 10-Q 2026-08-13 |
| Q1 2026 2026-03-31 | $1.4M | -$3.5M | -$3.0M | $4.6M | $3.5M | $4.6M | 10-Q 2026-05-15 |
| Q4 2025 2025-12-31 | $1.5M | -$2.8M | -$2.2M | $3.8M | No debt tags | $3.9M | 10-K 2026-03-27 |
| Q3 2025 2025-09-30 | $1.2M | -$3.3M | -$3.8M | $3.4M | No debt tags | $3.2M | 10-Q 2025-11-13 |
| Q2 2025 2025-06-30 | $564K | -$2.8M | -$2.2M | $7.8M | No debt tags | $2.9M | 10-Q 2026-08-13 |
| Q1 2025 2025-03-31 | $726K | -$3.6M | -$2.5M | $10.3M | No debt tags | $3.3M | 10-Q 2026-05-15 |
| Q4 2024 2024-12-31 | $770K | -$3.1M | -$2.8M | $6.5M | No debt tags | $3.3M | 10-K 2026-03-27 |
| Q3 2024 2024-09-30 | $887K | -$3.2M | -$2.3M | $9.2M | No debt tags | $3.3M | 10-Q 2025-11-13 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document PROSPECTUS SUPPLEMENT | 424B5 | 2026-10-16 |
| Latest annual report ANNUAL REPORT | 10-K | 2026-03-27 |
| Latest quarterly / interim QUARTERLY REPORT | 10-Q | 2026-11-16 |
| Latest current report CURRENT REPORT | 8-K | 2026-11-12 |
| Latest proxy DEFINITIVE PROXY STATEMENT | DEF 14A | 2026-06-23 |
Source: SEC EDGAR submissions feed, 302 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -14.0% |
| 1 month | -51.2% |
| 3 months | -76.3% |
| Year to date | -95.8% |
| 1 year | -96.6% |
| From 52-week high | -96.6% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Other listings for this company
| Ticker | Name | Price |
|---|---|---|
| TNONW | Tenon Medical Inc. Warrant | $0.0049 |
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| XAIR | Beyond Air Inc. | $2.02 | -5.16% | $3.4M |
| NVNO | enVVeno Medical Corporation | $5.95 | -3.65% | $4.1M |
| SNOA | Sonoma Pharmaceuticals Inc. | $0.8802 | -19.25% | $4.5M |
| BDMD | Baird Medical Investment Holdings Ltd Ordinary Share | $0.1065 | +17.68% | $4.5M |
| ICU | SeaStar Medical Holding Corporation | $0.8535 | +1.80% | $4.5M |
| VVOS | Vivos Therapeutics Inc. | $0.0822 | -16.12% | $2.8M |
| IVF | INVO Fertility Inc. | $2.40 | -7.69% | $2.8M |
| ICCM | IceCure Medical Ltd. | $0.7601 | +4.12% | $2.6M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier